THE EFFECT OF EXOGENOUS GLUCAGON LIKE PEPTIDE-1 (GLP-1) ON SMALL INTESTINAL GLUCOSE MISORPTION UN THE CRITICALLY ILL

被引：0
|
作者：
Cousins, C. E. [1 ]
Miller, A. [1 ]
Plummer, M. P. [1 ,2 ,3 ]
Deane, A. M. [1 ,2 ,3 ]
Horowitz, M. [4 ]
Chapman, M. J. [1 ,2 ,3 ]
机构：
[1] Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Adelaide, SA, Australia
[3] Ctr Clin Res Excellence Nutr Physiol Intervent &, Adelaide, SA, Australia
[4] Univ Adelaide, Discipline Med, Adelaide, SA, Australia
来源：
INTENSIVE CARE MEDICINE | 2014年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0519
引用
收藏
页码：S147 / S148
页数：2
相关论文
共 50 条
  • [41] Can glucagon-like peptide-1(GLP-1) analogues make neuroprotection a reality?
    Maryna V.Basalay
    Sean M.Davidson
    Derek M.Yellon
    NeuralRegenerationResearch, 2020, 15 (10) : 1852 - 1853
  • [42] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
  • [43] Somatostatin is a major, paracrine regulator of glucagon-like peptide-1 (GLP-1) secretion
    Hansen, L
    Mineo, H
    Bisgaard, T
    Jorgensen, PN
    Holst, JJ
    DIABETOLOGIA, 1997, 40 : 498 - 498
  • [44] Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
    Abba J. Kastin
    Victoria Akerstrom
    Weihong Pan
    Journal of Molecular Neuroscience, 2002, 18 : 7 - 14
  • [45] Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
    Unger J.R.
    Parkin C.G.
    Diabetes Therapy, 2011, 2 (1) : 29 - 39
  • [46] Glucagon-like peptide-1 (GLP-1) action in the mouse area postrema neurons
    Kawatani, Masahiro
    Yamada, Yuichiro
    Kawatani, Masahito
    PEPTIDES, 2018, 107 : 68 - 74
  • [47] Metabolic responses and benefits of glucagon-like peptide-1 (GLP-1) receptor ligands
    Tanday, Neil
    Flatt, Peter R.
    Irwin, Nigel
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 526 - 541
  • [48] Splenic Artery Thrombosis and Glucagon-like Peptide-1 (GLP-1) Agonist: Is There an Association?
    Lee, Regis
    Alukal, Joseph J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2966 - S2967
  • [49] Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
    Mabilleau, Guillaume
    Pereira, Marie
    Chenu, Chantal
    JOURNAL OF ENDOCRINOLOGY, 2018, 236 (01) : R29 - R42
  • [50] Glucagon-like peptide-1 (GLP-1) is a powerful inhibitor of gastric emptying in man
    Näslund, E
    Skogar, S
    Grybäck, P
    Jacobsson, H
    Holst, JJ
    Hellström, PM
    GASTROENTEROLOGY, 1998, 114 (04) : A810 - A810
12345